hims glp 1 compound Hims? Hers? It's Novo Nordisk's Semaglutide Market Now HIMS to Introduce Compounded GLP-1

Many patients experience a weight-loss plateau after steady early progress on GLP-1 therapy

Maintenance doses vary between individuals based on response and tolerability

Irfan Khan, MD Table of Contents: What are Semaglutide GLP-1 injections

Among 3,183 high-risk patients with type 2 diabetes, oral semaglutide cut cardiovascular deaths by 51% (HR 0.49) and reduced all-cause mortality by 49% (HR 0.51) over a median follow-up of 15.9 months

Conservative management strategies include: Optimize gastrointestinal function: Address constipation proactively with adequate hydration (individualized to the patient's cardiovascular and renal status), dietary fiber supplementation, and when necessary, osmotic laxatives such as polyethylene glycol